23andMe offers genetic tests for individuals to access their genome. The latest round of investments will help the company expand operations in the United States and around the globe in addition to providing capital for new laboratory space.
New investors joining the latest round include Casdin Capital, WuXi Healthcare Ventures and Xfund. Existing investors include Illumina, New Enterprise Associates, MPM Capital and Google Ventures.
More articles on startups:
Startup Insider: Zest Health
StartUp Health, GE Ventures to develop 10 digital health startups
Allscripts partners with Israeli digital innovation lab to bring startups to US
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.